← Open Payments lookup

UMAIR MALIK: Open Payments

NPI 1770679938 · THORNDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,751 in 49 payments from 20 companies in 2025. Trend: 2023 $1,760 · 2024 $1,918 · 2025 $1,751

Food & beverage: $1,751
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$416
AstraZeneca Pharmaceuticals LP3$284
ABBVIE INC.6$234
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$116
Calliditas Therapeutics US Inc.2$112
Braeburn Inc.4$102
Lilly USA, LLC3$68
Novo Nordisk Inc3$65
Aurinia Pharma U.S., Inc.2$47
Indivior Inc.2$45

Products named: CAPLYTA, BREZTRI, VRAYLAR, TARPEYO, BRIXADI, XIFAXAN, LUPKYNIS, Rybelsus.

Industry payments across PA — which companies pay providers there.